Latest News & Updates

Breaking News

  • 7 minutes ago

  • Simantini Singh Deo

Polyrizon Moves Closer To First-In-Human Trials As New CRO Agreement Enables Comprehensive Testing For Its Intranasal Medical Device Technology Platform
Breaking News
Transpire Bio Inc. Appoints Ewan Livesey As New Head Of Business Development To Strengthen Strategic Growth Efforts

Simantini Singh Deo

Other trending news you may like to read

Polyrizon Moves Closer To First-In-Human Trials As New CRO Agreement Enables Comprehensive Testing For Its Intranasal Medical Device Technology Platform

Polyrizon signs a CRO agreement to begin ISO 10993 GLP biocompatibility studies in Q2 2026, advancing its intranasal medical device platform toward first-in-human trials.

Simantini Singh Deo

Pharma Now

Transpire Bio Inc. Appoints Ewan Livesey As New Head Of Business Development To Strengthen Strategic Growth Efforts

Transpire Bio appoints Ewan Livesey as Head of Business Development to lead in-licensing, out-licensing, and co-development for its inhaled therapeutics pipeline.

Simantini Singh Deo

Pharma Now

NovaBridge Biosciences Receives Positive Regulatory Feedback From The U.S. Food And Drug Administration (FDA) On Accelerated Approval Pathway For Givastomig

NovaBridge Biosciences gets positive U.S. Food and Drug Administration feedback on accelerated approval plans for givastomig in first-line gastroesophageal cancer.

Simantini Singh Deo

Pharma Now

Dyadic Applied BioSolutions Enters OEM Distribution Agreement With Integrated Biotherapeutics, LLC To Expand Global Access To Its Recombinant Proteins

Dyadic Applied BioSolutions signs an OEM deal with Integrated Biotherapeutics to expand global distribution of recombinant proteins and support commercial growth.

Simantini Singh Deo

Pharma Now